Oct 3 (Reuters) – Spectral Medical Inc said its
experimental treatment for sepsis – a common, oft-deadly
complication of infection – failed a late-stage study, stymieing
the company’s plans to bring…
The post UPDATE 2-Spectral Medical’s sepsis treatment fails late-stage study appeared first on NASDAQ.